Fundz

Zeria Pharmaceutical acquires Haupt Pharma Wulfling

PRIVATEOct 26, 2026

Acquiring Company

Zeria Pharmaceutical Co Ltd

Acquired Company

Haupt Pharma Wulfling GmbH

TokyoManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyPharmaceutical

Description

Zeria Pharmaceutical Co Ltd has announced the acquisition of equity interests in Haupt Pharma Wulfling GmbH, making it a sub-subsidiary. This acquisition aims to enhance Zeria's pharmaceutical operations and extend its market reach.

Who to call at Zeria Pharmaceutical Co Ltd, and when

When Zeria Pharmaceutical Co Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Zeria Pharmaceutical Co Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zeria Pharmaceutical Co Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zeria Pharmaceutical Co Ltd. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zeria Pharmaceutical Co Ltd

Location

Tokyo, Japan

About

Zeria Pharmaceutical Co Ltd is a leading pharmaceutical company specializing in the development and marketing of a wide range of medical products. The company is committed to improving the quality of life through innovative healthcare solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zeria Pharmaceutical Co Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Zeria Pharmaceutical Co Ltd's next move

Learn about Strategic plan

Frequently asked

Who acquired Haupt Pharma Wulfling GmbH?

Haupt Pharma Wulfling GmbH was acquired by Zeria Pharmaceutical Co Ltd, based in Tokyo. The deal was reported on October 26, 2026. Zeria Pharmaceutical Co Ltd is a leading pharmaceutical company specializing in the development and marketing of a wide range of medical products. Zeria Pharmaceutical Co Ltd is privately held and operates in Manufacturing.

When did Zeria Pharmaceutical Co Ltd acquire Haupt Pharma Wulfling GmbH?

Zeria Pharmaceutical Co Ltd's acquisition of Haupt Pharma Wulfling GmbH was reported on October 26, 2026. Zeria Pharmaceutical Co Ltd has announced the acquisition of equity interests in Haupt Pharma Wulfling GmbH, making it a sub-subsidiary. This acquisition aims to enhance Zeria's pharmaceutical operations and extend its market reach. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Haupt Pharma Wulfling GmbH do?

Haupt Pharma Wulfling GmbH is a prominent pharmaceutical manufacturer providing various services, including contract manufacturing and development. The company focuses on delivering high-quality products tailored to client specifications. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.